Tammy Furlong serves as Executive at Elevation Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Tammy Furlong has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 23, 2025 involved transacting 37,957 shares valued at $13.7K.
Tammy Furlong currently holds 1,208 shares of Elevation Oncology, Inc. (ELEV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tammy Furlong has been a net neutral trader of ELEV stock. They have purchased $0 and sold $0 worth of shares.
Tammy Furlong's most recent insider trade was on Jul 23, 2025, when they sold 37,957 shares at $0.36 per share.
Get notified when new Form 4 filings are submitted
| $0.72 |
| Discretionary |
| Aug 15, 2024 | ELEV | $0 | Option Exercise | 300 | $N/A | Discretionary |
| May 15, 2024 | ELEV | $0 | Option Exercise | 300 | $N/A | Discretionary |
| May 15, 2024 | ELEV | $373 | Payment | 100 | $3.73 | Discretionary |
| Feb 15, 2024 | ELEV | $1.1K | Payment | 403 | $2.77 | Discretionary |
| Feb 15, 2024 | ELEV | $0 | Option Exercise | 1,200 | $N/A | Discretionary |